Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The Type III secretion system (T3SS) ATPase is a highly conserved enzyme essential for the virulence of many Gram-negative pathogens, including Salmonella, Shigella, and Pseudomonas [1.4.3]. It belongs to the AAA+ family of ATPases and provides the energy required for the unfolding and translocation of effector proteins through the needle-like injectisome into host cells [1.3.5, 1.4.3]. In the flagellar system, the homologous ATPase (FliI) drives the export of flagellar subunits necessary for bacterial motility [1.2.1, 1.4.1]. Because these ATPases are critical for pathogenesis but not for bacterial survival under standard conditions, they are attractive targets for anti-virulence therapies that neutralize pathogens without exerting the strong selective pressure associated with traditional antibiotics [1.3.1, 1.3.5]. Small molecule inhibitors, such as salicylidene acylhydrazides and novel non-competitive inhibitors, have shown promise in blocking ATPase activity and reducing the secretion of virulence factors in various infection models [1.3.3, 1.3.5]. Targeting this enzyme offers a strategy to treat infections while potentially reducing the development of antibiotic resistance [1.3.1].
Inhibition of ATP hydrolysis and energy coupling to the T3SS export gate, preventing the secretion of virulence effector proteins [1.3.1, 1.3.3].
3 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Type III secretion system ATPase (SctN).